Respiratory Adenovirus Quantification with a Droplet Digital Polymerase Chain Reaction (ddPCR) Assay.
Respiratory Adenovirus Quantification with a Droplet Digital Polymerase Chain Reaction (ddPCR) Assay.
复制标题
使用微滴数字聚合酶链式反应 (ddPCR) 测定进行呼吸道腺病毒定量。
DOI：
10.1128/spectrum.00269-23
复制
发表时间：
2023-06-15
影响因子：
3.7
通讯作者：
中科院分区：
文献类型：
--
作者：
Human adenoviruses (HAdVs) are double-stranded DNA viruses that can cause a wide spectrum of disease, including respiratory infections. Little is known about the value of respiratory HAdV quantification and its correlation with disease severity. In this study, we developed a quantitative HAdV droplet digital PCR (ddPCR) assay to study the association between viral loads, circulating types, and clinical outcomes. Remnant respiratory specimens positive for HAdV after the standard of care testing were collected from December 2020 to April 2022. A total of 129 samples were tested by a ddPCR method. Typing was performed using Nanopore sequencing of the hexon gene hypervariable region. Clinical chart reviews were performed to correlate the viral loads with the disease severity. The ddPCR assay showed an analytical sensitivity and a lower limit of quantification below 100 copies/mL. Of 129 positive clinical samples, 100 were quantified by ddPCR, 7 were too concentrated to be quantified, and 22 were negative. Of the 22 false negatives, only 3 were successfully typed; however, 99 of the 107 positive samples had a characterized genotype. The main HAdV types identified in this cohort were C1 (49.5%) followed by C2 (34.3%). No significant difference in HAdV loads was noted between patients who were admitted, those who required supplemental oxygen, and outpatients or between different HAdV types. HAdV ddPCR is a reliable absolute quantification approach for HAdV from respiratory samples. HAdV loads at initial presentation does not appear to differ between patients who require hospitalization versus outpatients. IMPORTANCE Measuring viral load using droplet digital PCR (ddPCR) is an absolute quantification approach that can facilitate comparability between different laboratories. This approach could prove valuable in studies that focus on the clinical utility of quantification. In this study, we evaluate a human adenovirus (HAdV) ddPCR assay and study the relationship between viral loads and outcomes after HAdV respiratory infections.
登录
查看更多内容
Casirivimab/imdevimab和Remdesivir的联合疗法用于B细胞耗尽的患者中旷日持久的SARS-COV-2感染。
影响因子：
4.2
作者：
Dioverti, M. Veronica;Gaston, David C.;Morris, C. Paul;Huff, Carol Ann;Jain, Tania;Jones, Richard;Anders, Viki;Lederman, Howard;Saunders, Jacqueline;Mostafa, Heba H.;Avery, Robin K.
通讯作者：
Avery, Robin K.
影响因子：
5.6
作者：
Esposito S;Scala A;Bianchini S;Zampiero A;Fossali E;Principi N
通讯作者：
Principi N
影响因子：
8.4
作者：
Goikhman, Yaniv;Drori, Yaron;Mandelboim, Michal
通讯作者：
Mandelboim, Michal
DOI：
10.1093/cid/ciaa1616
发表时间：
2021-08-16
期刊：
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子：
--
作者：
Gniazdowski V;Paul Morris C;Wohl S;Mehoke T;Ramakrishnan S;Thielen P;Powell H;Smith B;Armstrong DT;Herrera M;Reifsnyder C;Sevdali M;Carroll KC;Pekosz A;Mostafa HH
通讯作者：
Mostafa HH
影响因子：
4.9
作者：
Ko, Dae-Hyun;Kim, Hyun Soo;Song, Wonkeun
通讯作者：
Song, Wonkeun